Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Carcinoma × Oxaliplatin × Clear all

Phase

Phase 2 5 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 84 Stomach Neoplasms 51 Rectal Neoplasms 47 Colonic Neoplasms 43 Pancreatic Neoplasms 18 Neoplasms 14 Carcinoma, Hepatocellular 13 Neoplasm Metastasis 12 Lymphoma, Large B-Cell, Diffuse 9 Cholangiocarcinoma 8 Adenocarcinoma Of Esophagus 8 Adenocarcinoma 8 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Esophageal Neoplasms 5 Esophageal Squamous Cell Carcinoma 4 Lymphoma, Extranodal NK-T-Cell 3 Gallbladder Neoplasms 3 Biliary Tract Neoplasms 3 Neurotoxicity Syndromes 2 Lymphoma 2 Liver Neoplasms 2 Hepatoblastoma 2 Gastrointestinal Neoplasms 2 Gastrointestinal Diseases 2 Colorectal Adenocarcinoma 2 Resectable Colon Cancer 1 Recurrence 1 Rectal Diseases 1 Radiation Injuries 1 Peritoneal Neoplasms 1

Interventions

Carboplatin 15 Cisplatin 12 Paclitaxel 11 Pemetrexed 10 pembrolizumab 9 Gemcitabine 7 Docetaxel 6 durvalumab 4 Sorafenib 4 130-nm albumin-bound paclitaxel 4 osimertinib 3 cabozantinib 3 Taxes 3 Radiotherapy 3 Mitomycin 3 Magnetic Resonance Spectroscopy 3 Cetuximab 3 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 3 trifluridine tipiracil drug combination 2 regorafenib 2 padeliporfin 2 olaparib 2 atezolizumab 2 Sunitinib 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Radiation 2 Nivolumab 2 Irinotecan 2 Everolimus 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02539537 2024-01-09

NEOPAN

UNICANCER

Phase 3 Completed

Gastrointestinal

Carcinoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡